Proton-pump inhibitor overuse: a cautionary tale in misguided benefit

Intern Med J. 2019 Oct;49(10):1337. doi: 10.1111/imj.14452.

Authors

Karthik Nath¹, Reza Reyaldeen^{1

2}, Dharmenaan Palamuthusingam^{1

3}

Affiliations

¹ Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
² Department of Cardiology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
³ Department of Nephrology, Logan Hospital, Brisbane, Queensland, Australia.

PMID: 31602763
DOI: 10.1111/imj.14452

No abstract available

Publication types

Letter
Comment

MeSH terms

Cost-Benefit Analysis
Hematology*
Humans
Proton Pump Inhibitors*

Substances

Proton Pump Inhibitors